Article
Geldanamycin attenuates NO-mediated dilation in human skin
1 Jan 2002
Abstract excerpt
The binding of heat shock protein 90 (HSP90) to endothelial nitric oxide (NO) synthase (eNOS) can enhance eNOS activation. Studies have shown that the HSP90-specific inhibitor geldanamycin (GA) can cause attenuation of NO-mediated processes. Twenty subjects participated in one of two protocols. In each protocol, one forearm of each subject was instrumented with two intradermal microdialysis probes for drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
